NCT07299773Not yet recruiting
Evaluation of Patients With Hypertensive Disorders of Pregnancy: An Ambispective Observational Study
Source: ClinicalTrials.gov · Last updated 23 Dec 2025
Brief summary (registry, in English)
The overall objective of this study is to evaluate the prognostic role of ultrasound and laboratory parameters, specifically their potential ability to predict severe forms of preeclampsia and adverse maternal-fetal outcomes. In particular, the aim of the present research is to obtain data on the prognostic value of ultrasonographic and biochemical parameters in patients with hypertensive disorders of pregnancy.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 25 Nov 2025
- Start date
- 1 Jan 2026
- Primary completion date
- 1 Dec 2027
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- High blood pressure
- NCT number
- NCT07299773
What you commit to
- Study type: Observational
- Planned participants: 120
- From 1 Jan 2026 to the primary completion date, 1 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Maternal cardiac disease or ongoing cardiologic therapy
- Chronic kidney disease
- Pregestational diabetes
Other
- intrauterine fetal demise
- Major fetal anomalies or chromosomal abnormalities
- Twin or multiple pregnancies
Who the study is looking for
- Pregnancies complicated by preeclampsia or gestational hypertension ≥22 weeks
- Age ≥18 years
- Signed informed consent
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.